Recursion Pharmaceuticals, Inc. RXRX Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s deferred tax assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported deferred tax assets of $18.28M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s deferred tax assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s deferred tax assets decreased by 18.5% year-over-year, from $22.44M to $18.28M.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.